0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover186.79%IV52.47%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0393Delta0.0327Gamma7.01Leverage Ratio-0.0042Theta-0.0002Rho-0.28Eff Leverage0.0012Vega
Prime Medicine Stock Discussion
Down -12%
Net Inflow 154.87
XL in 136.33
XL out 0
$Prime Medicine(PRME.US)$ $NVIDIA(NVDA.US)$
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...
NEWS
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
No comment yet